These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26775841)

  • 21. Activation of SphK1 by K6PC-5 Inhibits Oxygen-Glucose Deprivation/Reoxygenation-Induced Myocardial Cell Death.
    Shao JJ; Peng Y; Wang LM; Wang JK; Chen X
    DNA Cell Biol; 2015 Nov; 34(11):669-76. PubMed ID: 26308910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells.
    Ahmed M; Hussain AR; Siraj AK; Uddin S; Al-Sanea N; Al-Dayel F; Al-Assiri M; Beg S; Al-Kuraya KS
    Mol Cancer; 2015 Jul; 14():131. PubMed ID: 26159723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and Biological Evaluation of PF-543 Derivative Containing Aliphatic Side Chain.
    Kim SW; Lee T; Oh YS; Shin SM; Lee JY; Kim S; Baek DJ; Park EY
    Chem Pharm Bull (Tokyo); 2019; 67(6):599-603. PubMed ID: 31155566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor is an effective radiosensitizer for colorectal cancer.
    Chen YH; Wei MF; Wang CW; Lee HW; Pan SL; Gao M; Kuo SH; Cheng AL; Teng CM
    Cancer Lett; 2015 Feb; 357(2):582-90. PubMed ID: 25497009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resistance to dual blockade of the kinases PI3K and mTOR in KRAS-mutant colorectal cancer models results in combined sensitivity to inhibition of the receptor tyrosine kinase EGFR.
    Belmont PJ; Jiang P; McKee TD; Xie T; Isaacson J; Baryla NE; Roper J; Sinnamon MJ; Lee NV; Kan JL; Guicherit O; Wouters BG; O'Brien CA; Shields D; Olson P; VanArsdale T; Weinrich SL; Rejto P; Christensen JG; Fantin VR; Hung KE; Martin ES
    Sci Signal; 2014 Nov; 7(351):ra107. PubMed ID: 25389372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gab3 is required for human colorectal cancer cell proliferation.
    Xiang S; Wang N; Hui P; Ma J
    Biochem Biophys Res Commun; 2017 Mar; 484(4):719-725. PubMed ID: 28115166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 4SC-202 activates ASK1-dependent mitochondrial apoptosis pathway to inhibit hepatocellular carcinoma cells.
    Fu M; Wan F; Li Z; Zhang F
    Biochem Biophys Res Commun; 2016 Mar; 471(2):267-73. PubMed ID: 26773495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SphK1-driven autophagy potentiates focal adhesion paxillin-mediated metastasis in colorectal cancer.
    Wu JN; Lin L; Luo SB; Qiu XZ; Zhu LY; Chen D; Wei ED; Fu ZH; Qin MB; Liang ZH; Huang JA; Liu SQ
    Cancer Med; 2021 Sep; 10(17):6010-6021. PubMed ID: 34268882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sphingosine kinase 2 inhibitor SG-12 induces apoptosis via phosphorylation by sphingosine kinase 2.
    Hara-Yokoyama M; Terasawa K; Ichinose S; Watanabe A; Podyma-Inoue KA; Akiyoshi K; Igarashi Y; Yanagishita M
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2220-4. PubMed ID: 23434415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tanshinone I induces human colorectal cancer cell apoptosis: The potential roles of Aurora A-p53 and survivin-mediated signaling pathways.
    Lu M; Wang C; Wang J
    Int J Oncol; 2016 Aug; 49(2):603-10. PubMed ID: 27279458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of dansyl labeled sphingosine kinase 1 inhibitor.
    Park EY; Lee T; Oh YS; Lee JY; Shrestha J; Hong SW; Jin YJ; Jo G; Kim S; Hwang GT; Han DS; Baek DJ
    Chem Phys Lipids; 2018 Sep; 215():29-33. PubMed ID: 30044952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ergosterol peroxide from Chaga mushroom (Inonotus obliquus) exhibits anti-cancer activity by down-regulation of the β-catenin pathway in colorectal cancer.
    Kang JH; Jang JE; Mishra SK; Lee HJ; Nho CW; Shin D; Jin M; Kim MK; Choi C; Oh SH
    J Ethnopharmacol; 2015 Sep; 173():303-12. PubMed ID: 26210065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. α-Melanocyte stimulating hormone attenuates dexamethasone-induced osteoblast damages through activating melanocortin receptor 4-SphK1 signaling.
    Guo S; Xie Y; Fan JB; Ji F; Wang S; Fei H
    Biochem Biophys Res Commun; 2016 Jan; 469(2):281-7. PubMed ID: 26631960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resveratrol elicits anti-colorectal cancer effect by activating miR-34c-KITLG in vitro and in vivo.
    Yang S; Li W; Sun H; Wu B; Ji F; Sun T; Chang H; Shen P; Wang Y; Zhou D
    BMC Cancer; 2015 Dec; 15():969. PubMed ID: 26674205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Verification of the Necessity of the Tolyl Group of PF-543 for Sphingosine Kinase 1 Inhibitory Activity.
    Kim SB; Lee T; Moon HS; Ki SH; Oh YS; Lee JY; Kim SB; Park JE; Kwon Y; Kim S; Baek DJ; Park EY
    Molecules; 2020 May; 25(11):. PubMed ID: 32471162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 1Alpha,25-dihydroxyvitamin D3 inhibits programmed cell death in HL-60 cells by activation of sphingosine kinase.
    Kleuser B; Cuvillier O; Spiegel S
    Cancer Res; 1998 May; 58(9):1817-24. PubMed ID: 9581819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The synthetic flavonoid WYC02-9 inhibits colorectal cancer cell growth through ROS-mediated activation of MAPK14 pathway.
    Chen YJ; Chen HP; Cheng YJ; Lin YH; Liu KW; Chen YJ; Hou MF; Wu YC; Lee YC; Yuan SS
    Life Sci; 2013 Jun; 92(22):1081-92. PubMed ID: 23624232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SphK1 modulates cell migration and EMT-related marker expression by regulating the expression of p-FAK in colorectal cancer cells.
    Xu CY; Liu SQ; Qin MB; Zhuge CF; Qin L; Qin N; Lai MY; Huang JA
    Int J Mol Med; 2017 May; 39(5):1277-1284. PubMed ID: 28405684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-inflammatory nitro-fatty acids suppress tumor growth by triggering mitochondrial dysfunction and activation of the intrinsic apoptotic pathway in colorectal cancer cells.
    Kühn B; Brat C; Fettel J; Hellmuth N; Maucher IV; Bulut U; Hock KJ; Grimmer J; Manolikakes G; Rühl M; Kühn A; Zacharowski K; Matrone C; Urbschat A; Roos J; Steinhilber D; Maier TJ
    Biochem Pharmacol; 2018 Sep; 155():48-60. PubMed ID: 29909078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GSK1059615 kills head and neck squamous cell carcinoma cells possibly via activating mitochondrial programmed necrosis pathway.
    Xie J; Li Q; Ding X; Gao Y
    Oncotarget; 2017 Aug; 8(31):50814-50823. PubMed ID: 28881606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.